Bilirubin Meters Market Report 2024

The bilirubin meters market size has grown strongly in recent years. It will grow from $0.49 billion in 2023 to $0.53 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to increasing awareness of health conditions, supportive government policies and programs, a growing preference for home healthcare, an aging population, and economic development in emerging markets.

The bilirubin meters market size is expected to see strong growth in the next few years. It will grow to $0.71 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to the increasing incidence of neonatal jaundice, rising healthcare expenditure, the expansion of diagnostic centers, favorable reimbursement policies, and growth in medical tourism. Major trends expected during this period include innovations in bilirubin meter technology, development of hospital infrastructure, growing demand for point-of-care diagnostic devices, investments in research and development, and collaborations between manufacturers and healthcare providers.

The growing prevalence of liver diseases is expected to drive the expansion of the bilirubin meter market. Liver diseases include various conditions that affect liver function, often causing inflammation, scarring, or damage from factors such as infections, toxins, genetic disorders, or chronic diseases. The rise in liver diseases is attributed to increasing risk factors such as obesity, excessive alcohol consumption, viral infections, and lifestyle-related issues, alongside advancements in diagnostic capabilities. Bilirubin meters are crucial for managing these conditions as they provide accurate, non-invasive measurements of bilirubin levels, aiding in the diagnosis, monitoring, and treatment of liver dysfunction and jaundice. For example, a report from the Office for Health Improvement and Disparities in April 2024 indicated that premature deaths from hepatitis C have stabilized over the past three years, with 233 in 2022, 241 in 2021, and 237 in 2020. In 2022, England reported 5,776 premature deaths from alcoholic liver disease, with a rate of 11.6 deaths per 100,000 people under 75. Consequently, the increasing prevalence of liver diseases is fueling the growth of the bilirubin meter market.

Leading companies in the bilirubin meter market are focusing on developing advanced technologies, such as non-invasive bilirubin meters, to offer a quick, painless, and convenient method for monitoring bilirubin levels. Non-invasive bilirubin meters measure bilirubin without needing a blood sample, often using light-based techniques such as transcutaneous spectrophotometry. For instance, in November 2022, Yishan Medical, a China-based medical device company, introduced the Intelligent Neonatal Transdermal Jaundice Instrument. This device features exclusive optical detection technology developed by Yishan Medical, overcoming the cost barriers set by foreign technologies. Compact and user-friendly, it enhances portability and accessibility, making it ideal for primary jaundice monitoring in medical institutions and improving neonatal jaundice care at the primary healthcare level.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based medical device company, acquired DiaSys Diagnostic Systems GmbH for an undisclosed sum. This acquisition will help Mindray advance its supply chain platform, access an experienced international team, and strengthen its in-vitro diagnostics portfolio. Mindray plans to support DiaSys with resources and leverage its global integration experience to foster synergistic growth for both companies. DiaSys Diagnostic Systems GmbH is a Germany-based manufacturer of bilirubin meters.

Major companies operating in the bilirubin meters market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., PerkinElmer, Drägerwerk AG Co., Sysmex Corporation, Konica Minolta Business Solutions Inc., Masimo Corp., Beckman Coulter Inc., Nova Biomedical, Loewenstein Medical UK Ltd., Ningbo David Medical Device Co. Ltd., Reichert Inc., A. Menarini Diagnostics Srl, Mennen Co., Delta Medical International Ltd., AVI Healthcare Pvt Ltd., Olidef, Micro Lab Instruments, Aegis Medical Innovations Inc., Medi Waves Inc., Ginevri Srl.

North America was the largest region in the bilirubin meters market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bilirubin meters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bilirubin meters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A bilirubin meter is a medical device used to measure bilirubin concentration in a patient's blood. These meters can be either invasive, requiring a blood sample, or non-invasive, using transcutaneous methods to measure bilirubin levels through the skin. Bilirubin meters are crucial for the accurate and timely diagnosis and management of conditions related to the liver and red blood cell breakdown.

The main types of bilirubin meters include transcutaneous devices and benchtop devices. Transcutaneous devices measure bilirubin levels through the skin without invasive procedures. These devices are used for both neonates and adults to monitor conditions such as jaundice and hepatitis. They are commonly employed in hospitals, medical centers, and other healthcare settings.

The bilirubin meters market research report is one of a series of new reports that provides bilirubin meters market statistics, including bilirubin meters industry global market size, regional shares, competitors with a bilirubin meters market share, detailed bilirubin meters market segments, market trends and opportunities, and any further data you may need to thrive in the bilirubin meters industry. This bilirubin meters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bilirubin meter market consists of sales of serum bilirubin analyzers, phototherapy equipment, disposable bilirubin test strips and neonatal blood collection kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.